{"count":221272,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=696","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=694","results":[{"created":"2022-11-11T17:09:42.133469+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.883","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah5 has been classified as Red List (Low Evidence).","entity_name":"DNAH5","entity_type":"gene"},{"created":"2022-11-11T17:09:35.965377+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.883","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DNAH5 were changed from Primary ciliary dyskinesia to Ciliary dyskinesia, primary, 3, with or without situs inversus, MIM# 608644","entity_name":"DNAH5","entity_type":"gene"},{"created":"2022-11-11T17:07:40.006893+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.882","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DNAH5 as Red List (low evidence)","entity_name":"DNAH5","entity_type":"gene"},{"created":"2022-11-11T17:07:39.993050+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.882","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah5 has been classified as Red List (Low Evidence).","entity_name":"DNAH5","entity_type":"gene"},{"created":"2022-11-11T17:07:28.015360+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.881","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DNAH5: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Ciliary dyskinesia, primary, 3, with or without situs inversus, MIM# 608644; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"DNAH5","entity_type":"gene"},{"created":"2022-11-11T16:16:52.640322+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.881","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DNAH11 as ready","entity_name":"DNAH11","entity_type":"gene"},{"created":"2022-11-11T16:16:52.627802+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.881","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah11 has been classified as Red List (Low Evidence).","entity_name":"DNAH11","entity_type":"gene"},{"created":"2022-11-11T16:16:47.634394+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.881","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DNAH11 were changed from Primary ciliary dyskinesia to Ciliary dyskinesia, primary, 7, with or without situs inversus, MIM#611884","entity_name":"DNAH11","entity_type":"gene"},{"created":"2022-11-11T16:16:34.280057+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.880","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DNAH11 as Red List (low evidence)","entity_name":"DNAH11","entity_type":"gene"},{"created":"2022-11-11T16:16:34.270733+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.880","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnah11 has been classified as Red List (Low Evidence).","entity_name":"DNAH11","entity_type":"gene"},{"created":"2022-11-11T16:16:20.893401+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.879","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DNAH11: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Ciliary dyskinesia, primary, 7, with or without situs inversus, MIM#611884; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"DNAH11","entity_type":"gene"},{"created":"2022-11-11T16:14:40.163501+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.879","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DNAAF1 as ready","entity_name":"DNAAF1","entity_type":"gene"},{"created":"2022-11-11T16:14:40.153347+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.879","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnaaf1 has been classified as Red List (Low Evidence).","entity_name":"DNAAF1","entity_type":"gene"},{"created":"2022-11-11T16:14:35.414214+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.879","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DNAAF1 were changed from Primary ciliary dyskinesia to Ciliary dyskinesia, primary, 13, MIM# 613193","entity_name":"DNAAF1","entity_type":"gene"},{"created":"2022-11-11T16:14:22.002629+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.878","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DNAAF1 as Red List (low evidence)","entity_name":"DNAAF1","entity_type":"gene"},{"created":"2022-11-11T16:14:21.993463+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.878","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dnaaf1 has been classified as Red List (Low Evidence).","entity_name":"DNAAF1","entity_type":"gene"},{"created":"2022-11-11T16:14:09.478697+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.877","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DNAAF1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Ciliary dyskinesia, primary, 13, MIM# 613193; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"DNAAF1","entity_type":"gene"},{"created":"2022-11-11T16:11:56.160399+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.877","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DMXL2 as ready","entity_name":"DMXL2","entity_type":"gene"},{"created":"2022-11-11T16:11:56.152066+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.877","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dmxl2 has been classified as Red List (Low Evidence).","entity_name":"DMXL2","entity_type":"gene"},{"created":"2022-11-11T16:11:48.942813+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.877","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DMXL2 as Red List (low evidence)","entity_name":"DMXL2","entity_type":"gene"},{"created":"2022-11-11T16:11:48.933858+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.877","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dmxl2 has been classified as Red List (Low Evidence).","entity_name":"DMXL2","entity_type":"gene"},{"created":"2022-11-11T16:11:36.086100+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.876","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DMXL2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Epileptic encephalopathy, early infantile, 81, MIM# 618663; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"DMXL2","entity_type":"gene"},{"created":"2022-11-11T16:09:39.593766+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.876","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DMP1 as ready","entity_name":"DMP1","entity_type":"gene"},{"created":"2022-11-11T16:09:39.584005+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.876","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dmp1 has been classified as Green List (High Evidence).","entity_name":"DMP1","entity_type":"gene"},{"created":"2022-11-11T16:09:35.456851+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.876","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DMP1 were changed from Hypophosphatemic rickets, AR to Hypophosphatemic rickets MIM#241520","entity_name":"DMP1","entity_type":"gene"},{"created":"2022-11-11T16:09:20.567916+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.875","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DMP1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Hypophosphatemic rickets MIM#241520; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"DMP1","entity_type":"gene"},{"created":"2022-11-11T16:06:14.700953+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.875","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DLL3 as ready","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T16:06:14.693073+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.875","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dll3 has been classified as Red List (Low Evidence).","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T16:06:10.087001+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.875","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DLL3 were changed from Spondylocostal dysostosis, autosomal recessive, 1 to Spondylocostal dysostosis 1, autosomal recessive, MIM# 277300","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T16:05:54.953176+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.874","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DLL3 as Red List (low evidence)","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T16:05:54.943062+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.874","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dll3 has been classified as Red List (Low Evidence).","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T16:05:42.198755+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.873","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DLL3: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Spondylocostal dysostosis 1, autosomal recessive, MIM# 277300; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T16:04:11.699858+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.873","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DIAPH1 as ready","entity_name":"DIAPH1","entity_type":"gene"},{"created":"2022-11-11T16:04:11.691299+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.873","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: diaph1 has been classified as Red List (Low Evidence).","entity_name":"DIAPH1","entity_type":"gene"},{"created":"2022-11-11T16:04:02.631890+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.873","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DIAPH1 were changed from Deafness, autosomal dominant 1, with or without thrombocytopenia MIM#124900 to Seizures, cortical blindness, microcephaly syndrome, MIM# 616632; Deafness, autosomal dominant 1, with or without thrombocytopenia, MIM# 124900","entity_name":"DIAPH1","entity_type":"gene"},{"created":"2022-11-11T16:03:41.486575+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.872","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: DIAPH1 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"DIAPH1","entity_type":"gene"},{"created":"2022-11-11T16:03:27.931682+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.871","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DIAPH1 as Red List (low evidence)","entity_name":"DIAPH1","entity_type":"gene"},{"created":"2022-11-11T16:03:27.923310+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.871","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: diaph1 has been classified as Red List (Low Evidence).","entity_name":"DIAPH1","entity_type":"gene"},{"created":"2022-11-11T16:03:14.388614+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.870","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DIAPH1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Seizures, cortical blindness, microcephaly syndrome, MIM# 616632, Deafness, autosomal dominant 1, with or without thrombocytopenia, MIM# 124900; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"DIAPH1","entity_type":"gene"},{"created":"2022-11-11T15:31:46.932192+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.870","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DFNB59 as ready","entity_name":"DFNB59","entity_type":"gene"},{"created":"2022-11-11T15:31:46.922510+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.870","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dfnb59 has been classified as Green List (High Evidence).","entity_name":"DFNB59","entity_type":"gene"},{"created":"2022-11-11T15:31:39.820113+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.870","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DFNB59 were changed from Hearing loss to Deafness, autosomal recessive 59, MIM# 610220","entity_name":"DFNB59","entity_type":"gene"},{"created":"2022-11-11T15:31:26.133493+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.869","user_name":"Zornitza Stark","item_type":"entity","text":"Tag new gene name tag was added to gene: DFNB59.","entity_name":"DFNB59","entity_type":"gene"},{"created":"2022-11-11T15:31:16.200952+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.869","user_name":"Zornitza Stark","item_type":"entity","text":"commented on gene: DFNB59: DEFINITIVE by ClinGen, over 50 affected individuals from more than 10 families reported, supportive functional data including animal models.\r\n\r\nNew HGNC name is PJVK.\r\n\r\nHearing loss is pre-lingual, therefore include.\r\n\r\nTreatment: hearing aids/cochlear implant.","entity_name":"DFNB59","entity_type":"gene"},{"created":"2022-11-11T15:30:31.493301+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.869","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DFNB59: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Deafness, autosomal recessive 59, MIM# 610220; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"DFNB59","entity_type":"gene"},{"created":"2022-11-11T15:24:19.373149+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.869","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DFNA5 as ready","entity_name":"DFNA5","entity_type":"gene"},{"created":"2022-11-11T15:24:19.364483+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.869","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dfna5 has been classified as Red List (Low Evidence).","entity_name":"DFNA5","entity_type":"gene"},{"created":"2022-11-11T15:24:14.387833+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.869","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DFNA5 were changed from Hearing loss to Deafness, autosomal dominant 5, MIM# 600994","entity_name":"DFNA5","entity_type":"gene"},{"created":"2022-11-11T15:24:02.358549+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.868","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: DFNA5 as Red List (low evidence)","entity_name":"DFNA5","entity_type":"gene"},{"created":"2022-11-11T15:24:02.350337+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.868","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dfna5 has been classified as Red List (Low Evidence).","entity_name":"DFNA5","entity_type":"gene"},{"created":"2022-11-11T15:23:52.623735+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.867","user_name":"Zornitza Stark","item_type":"entity","text":"Tag new gene name tag was added to gene: DFNA5.","entity_name":"DFNA5","entity_type":"gene"},{"created":"2022-11-11T15:23:42.959110+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.867","user_name":"Zornitza Stark","item_type":"entity","text":"commented on gene: DFNA5: Assessed as DEFINITIVE by ClinGen, over a 150 affected individuals reported, supportive functional data including animal models.\r\n\r\nNew HGNC approved name is GSDME.\r\n\r\nHowever, age of onset is typically 11-50, therefore exclude.","entity_name":"DFNA5","entity_type":"gene"},{"created":"2022-11-11T15:22:58.857031+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.867","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: DFNA5: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Deafness, autosomal dominant 5, MIM# 600994; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"DFNA5","entity_type":"gene"},{"created":"2022-11-11T13:05:49.202457+11:00","panel_name":"Additional findings_Paediatric","panel_id":3302,"panel_version":"0.274","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: APOB as ready","entity_name":"APOB","entity_type":"gene"},{"created":"2022-11-11T13:05:49.194061+11:00","panel_name":"Additional findings_Paediatric","panel_id":3302,"panel_version":"0.274","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: apob has been classified as Green List (High Evidence).","entity_name":"APOB","entity_type":"gene"},{"created":"2022-11-11T13:04:53.909277+11:00","panel_name":"Additional findings_Paediatric","panel_id":3302,"panel_version":"0.274","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: APOB were changed from Apolipoprotein B deficiency to Hypercholesterolaemia, familial, 2, MIM# 144010; Hypobetalipoproteinaemia 615558","entity_name":"APOB","entity_type":"gene"},{"created":"2022-11-11T13:04:40.033305+11:00","panel_name":"Additional findings_Paediatric","panel_id":3302,"panel_version":"0.273","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: APOB was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"APOB","entity_type":"gene"},{"created":"2022-11-11T13:03:13.986848+11:00","panel_name":"Additional findings_Paediatric","panel_id":3302,"panel_version":"0.272","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: APOB: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Hypercholesterolaemia, familial, 2, MIM# 144010, Hypobetalipoproteinaemia 615558; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"APOB","entity_type":"gene"},{"created":"2022-11-11T10:57:07.263028+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.202","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: DLL3 as ready","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T10:57:07.252275+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.202","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: dll3 has been classified as Green List (High Evidence).","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T10:57:04.752237+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.202","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: DLL3 were changed from  to Spondylocostal dysostosis 1, autosomal recessive, MIM# 277300","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T10:56:38.961260+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.201","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: DLL3 were set to ","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T10:56:05.145267+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.200","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: DLL3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"DLL3","entity_type":"gene"},{"created":"2022-11-11T10:55:09.151265+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CREB3L1 as ready","entity_name":"CREB3L1","entity_type":"gene"},{"created":"2022-11-11T10:55:09.132087+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: creb3l1 has been classified as Green List (High Evidence).","entity_name":"CREB3L1","entity_type":"gene"},{"created":"2022-11-11T10:54:48.439241+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CREB3L1 were changed from  to Osteogenesis imperfecta, type XVI, 616229","entity_name":"CREB3L1","entity_type":"gene"},{"created":"2022-11-11T10:54:17.609548+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.198","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CREB3L1 were set to ","entity_name":"CREB3L1","entity_type":"gene"},{"created":"2022-11-11T10:53:47.975043+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.197","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CREB3L1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CREB3L1","entity_type":"gene"},{"created":"2022-11-11T10:52:50.470338+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.196","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: COL2A1 as ready","entity_name":"COL2A1","entity_type":"gene"},{"created":"2022-11-11T10:52:50.460339+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.196","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: col2a1 has been classified as Green List (High Evidence).","entity_name":"COL2A1","entity_type":"gene"},{"created":"2022-11-11T10:52:45.735161+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.196","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COL2A1 were changed from  to Collagenopathy type 2 alpha 1, MONDO:0022800","entity_name":"COL2A1","entity_type":"gene"},{"created":"2022-11-11T10:52:20.070386+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.195","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COL2A1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"COL2A1","entity_type":"gene"},{"created":"2022-11-11T10:51:29.281997+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: COL1A2 as ready","entity_name":"COL1A2","entity_type":"gene"},{"created":"2022-11-11T10:51:29.272660+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: col1a2 has been classified as Green List (High Evidence).","entity_name":"COL1A2","entity_type":"gene"},{"created":"2022-11-11T10:51:23.386888+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COL1A2 were changed from  to Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2, MIM# 619120; Ehlers-Danlos syndrome, arthrochalasia type, 2, MIM# 617821; Ehlers-Danlos syndrome, cardiac valvular type, MIM# 225320; Osteogenesis imperfecta, type II, MIM# 166210; Osteogenesis imperfecta, type III, MIM# 259420; Osteogenesis imperfecta, type IV, MIM# 166220","entity_name":"COL1A2","entity_type":"gene"},{"created":"2022-11-11T10:50:37.460106+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.193","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COL1A2 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"COL1A2","entity_type":"gene"},{"created":"2022-11-11T10:49:58.999896+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: COL11A2 as ready","entity_name":"COL11A2","entity_type":"gene"},{"created":"2022-11-11T10:49:58.990237+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: col11a2 has been classified as Green List (High Evidence).","entity_name":"COL11A2","entity_type":"gene"},{"created":"2022-11-11T10:49:56.069524+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COL11A2 were changed from  to Fibrochondrogenesis 2, MIM# 614524; Otospondylomegaepiphyseal dysplasia, autosomal recessive, MIM# 215150","entity_name":"COL11A2","entity_type":"gene"},{"created":"2022-11-11T10:49:21.117633+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.191","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COL11A2 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"COL11A2","entity_type":"gene"},{"created":"2022-11-11T10:48:34.512764+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.190","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: COL11A1 as ready","entity_name":"COL11A1","entity_type":"gene"},{"created":"2022-11-11T10:48:34.496400+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.190","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: col11a1 has been classified as Green List (High Evidence).","entity_name":"COL11A1","entity_type":"gene"},{"created":"2022-11-11T10:48:31.378046+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.190","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: COL11A1 were changed from  to Fibrochondrogenesis 1, MIM# 228520; Marshall syndrome, MIM# 154780","entity_name":"COL11A1","entity_type":"gene"},{"created":"2022-11-11T10:48:00.888039+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.189","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: COL11A1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"COL11A1","entity_type":"gene"},{"created":"2022-11-11T10:47:18.980199+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.188","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CANT1 as ready","entity_name":"CANT1","entity_type":"gene"},{"created":"2022-11-11T10:47:18.964699+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.188","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cant1 has been classified as Green List (High Evidence).","entity_name":"CANT1","entity_type":"gene"},{"created":"2022-11-11T10:47:13.807253+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.188","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CANT1 were changed from  to Desbuquois dysplasia 1, MIM# 251450","entity_name":"CANT1","entity_type":"gene"},{"created":"2022-11-11T10:46:49.145761+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.187","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CANT1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CANT1","entity_type":"gene"},{"created":"2022-11-11T10:45:53.858254+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.186","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MEOX1 as ready","entity_name":"MEOX1","entity_type":"gene"},{"created":"2022-11-11T10:45:53.849585+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.186","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: meox1 has been classified as Green List (High Evidence).","entity_name":"MEOX1","entity_type":"gene"},{"created":"2022-11-11T10:45:48.369730+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.186","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MEOX1 as Green List (high evidence)","entity_name":"MEOX1","entity_type":"gene"},{"created":"2022-11-11T10:45:48.360471+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.186","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: meox1 has been classified as Green List (High Evidence).","entity_name":"MEOX1","entity_type":"gene"},{"created":"2022-11-11T10:44:59.687551+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MBTPS1 as ready","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2022-11-11T10:44:59.678714+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mbtps1 has been classified as Green List (High Evidence).","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2022-11-11T10:44:56.257268+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MBTPS1 were changed from ?Spondyloepiphyseal dysplasia, Kondo-Fu type - MIM#618392 to Spondyloepiphyseal dysplasia, Kondo-Fu type - MIM#618392","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2022-11-11T10:44:17.380812+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.184","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MBTPS1 as Green List (high evidence)","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2022-11-11T10:44:17.372902+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.184","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mbtps1 has been classified as Green List (High Evidence).","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2022-11-11T10:42:53.102138+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.183","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MATN3 as ready","entity_name":"MATN3","entity_type":"gene"},{"created":"2022-11-11T10:42:53.086003+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.183","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: matn3 has been classified as Green List (High Evidence).","entity_name":"MATN3","entity_type":"gene"},{"created":"2022-11-11T10:42:49.030248+11:00","panel_name":"Skeletal Dysplasia_Fetal","panel_id":28,"panel_version":"0.183","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MATN3 as Green List (high evidence)","entity_name":"MATN3","entity_type":"gene"}]}